Partnerships Propel Stellar Biotechnologies' Vaccine Technology
Source: Tracy Salcedo of The Life Sciences Report  (6/22/16)
Maxim analyst Jason McCarthy sees nothing but blue sky for Stellar Biotechnologies Inc., even though its product originated in the deep blue sea. With blockbuster indications like cancer, lupus and Alzheimer's disease being targeted by partners, and a manufacturing process sure to satisfy regulators, McCarthy lays out a value proposition for Stellar's KLH that investors should not ignore. More >

Are Copper and China Set to Rally?
Source: Clive Maund  (6/21/16)
Technical analyst and newsletter writer Clive Maund explores the link between an anticipated copper rally and an upswing in Chinese markets. More >

Is It Time to Dump Gold and Buy Platinum?
Source: Bob Moriarty  (6/20/16)
Bob Moriarty explains why precious metals investors may want to look beyond gold to a commodity with a long history and an interesting relationship to the yellow metal. More >

Oil Prices Send Sell Signal
Source: Jack Chan  (6/20/16)
Technical analyst Jack Chan believes a correction in oil prices is underway, and advises investors to use caution in a vulnerable market. More >

Will Brexit Vote Push US Dollar One Way or the Other?
Source: Jack Chan  (6/20/16)
With both gold and silver ETFs trading in heavy volumes last week, technical analyst Jack Chan suspects liquidation is occurring, and speculates that the upcoming Brexit vote could impact the U.S. dollar. More >

Commercial Traders Have Just Gone Over the Top
Source: Michael Ballanger  (6/18/16)
Precious metals expert Michael Ballanger examines Friday's COT report and discusses its implication for investors. More >

NexGen Drilling Reveals Massive Pitchblende
Source: The Gold Report  (6/17/16)
Drilling has revealed massive pitchblende near NexGen Energy's Arrow zone on the Rook 1 property in the Athabasca Basin. Here's what the analysts have to say. More >

The Fed Giveth and the Bullion Banks Taketh Away…
Source: Michael J. Ballanger  (6/16/16)
Precious metal expert Michael Ballanger breaks down the gold price roller coaster surrounding the Fed's decision not to raise interest rates. More >

Soligenix Develops Defenses Against Bioterrorism
Source: Staff of The Life Sciences Report  (6/15/16)
Maxim Group biotech analyst Jason Kolbert notes "steady progress" is being made by Soligenix Inc., a small-cap biotech with programs addressing bioterrorism threats and a devastating side effect of cancer treatment, in his Q1/16 update on the company. More >

Quaterra's Agreement with Freeport Nevada Extends Yerington Funding
Source: Special to The Gold Report  (6/14/16)
Quaterra Resources Inc. and its subsidiary Singatse Peak Services announced earlier this week that they had reached an agreement with Freeport Nevada to extend for up to two years the current Stage 2 of Freeport Nevada's option to acquire an interest in the company's Yerington Copper Project in Nevada. Gerald Prosalendis, recently appointed president and COO of Quaterra Resources, explains what this extension means for Quaterra and the Yerington project. More >

George Soros Making Big Bets on Gold
Source: Michael J. Ballanger  (6/11/16)
George Soros has joined fellow billionaire investors Stan Druckenmiller and Ray Dalios on investing big in gold. Precious metals expert Michael Ballanger explains what is behind these moves. More >

Five Junior Mining Companies Creating Value Through Exploration
Source: Special to The Gold Report  (6/9/16)
The drill bit is essential to junior mining companies. Only through active exploration can investors separate the companies with potential from those without. Mick Carew of Haywood Securities discusses five companies on track to create value through the drill bit. More >

Investment in Cell and Gene Therapies Ramps Up
Source: George S. Mack of The Life Sciences Report  (6/8/16)
After decades of disappointment, cell therapies and gene therapies are finally seeing light at the end of the tunnel. Investors, investigators, clinicians, and patients with serious unmet needs are watching pivotal trials move into the home stretch. Yes. . .pivotal data are actually on the way. More >

Jobs Report Changes the Landscape for Gold
Source: Brien Lundin  (6/7/16)
Gold soars as chances for a Fed rate hike this month evaporate. Brien Lundin, editor of Gold Newsletter, details what that means for investors. More >

Reservoir Minerals: A Rare Opportunity
Source: Adrian Day  (6/6/16)
Fund Manager Adrian Day has said that while Nevsun's acquisition of Reservoir Minerals would be a great deal for Nevsun and would create a new, well-financed mid-size base metals company, the offer undervalues Reservoir. Day discusses a rival proposal that has just come forth. More >

Two Rising Mining Companies for an Uncertain Market
Source: Jayant Bhandari  (6/6/16)
The market has its moods and its fascination with headlines. Greece, Ukraine, ISIS, emerging markets—crises come and go. Investment adviser Jayant Bhandari discusses the role of gold in uncertain times and profiles two companies he believes have generated more value than their share price increase reflects or have gone unappreciated by the market. More >

Crude Oil Is Due for a Correction
Source: Jack Chan  (6/6/16)
Technical analyst Jack Chan demonstrates the divergence between oil equity prices and the underlying commodity. More >

Is the Gold Pullback Complete?
Source: Jack Chan  (6/6/16)
Technical analyst Jack Chan examines the charts after Friday's spike in gold.
More >

Three Buying Opportunities in a Resurgent Gold Market
Source: Gwen Preston  (6/3/16)
After gold nearly reached $1,300/oz in early May, it has been trading lower, but Gwen Preston of Resource Maven is not worried. She sees this as the correction after the big gain and believes the new bull market is intact. In this article for The Gold Report, Preston discusses three companies that offer good opportunities in today's market. More >

$50/Barrel Oil Won't Last: Why Chances of a Breakdown Are High
Source: Clive Maund  (6/3/16)
Technical analyst and newsletter writer Clive Maund lists the reasons he believes oil prices, which recently peaked above $50/barrel, are headed for a fall. More >

OncoSec Delivers Cancer Therapy Straight to the Tumor
Source: Special to The Life Sciences Report  (6/1/16)
Cancer patients often receive multiple rounds of chemotherapy, with new drugs incorporated into treatment programs as tumors develop resistance. OncoSec Medical Incorporated's Punit Dhillon describes how his company is challenging that paradigm with a proprietary platform that delivers therapeutic agents directly to the tumor, while also laying a foundation for expanded use of combination immunotherapies at the forefront of cancer treatment. More >

Why Technical Analysis Does Not Work for Gold and Silver
Source: Michael Ballanger  (6/1/16)
Michael Ballanger, a precious metals expert, says he believes technical charts were created by bullion bank traders to lull the "chartists" into a false sense of security. More >

Four Active Mining Companies You Should Be Watching
Source: Special to The Gold Report  (5/31/16)
The mining industry has been very busy over the last few months with the gold price showing signs of stabilizing, financings getting completed, preliminary economic assessments being released, prefeasibility studies being updated and M&A activity increasing. The market has a buzz once again and Thibaut Lepouttre of Caesars Report profiles several companies that are reaping the rewards of being very active right now. More >

The Numbers Add Up to Vindication for a Cautious Gold Bull. . .
Source: Michael Ballanger  (5/28/16)
Precious metals expert Michael Ballanger discusses the importance of caution and timing in gold investment. More >

What Recent Moves in the US Dollar Mean for Gold
Source: Jack Chan  (5/28/16)
Technical analyst Jack Chan offers an interpretation of the correction in progress in the gold sector. More >